Five Day Monthly Diet Reduces Crohn's Disease Symptoms and Inflammation
Stanford study shows fasting-mimicking diet for 5 days monthly improved symptoms in two-thirds of Crohn's patients while reducing inflammation markers.
Summary
A Stanford Medicine clinical trial found that a fasting-mimicking diet practiced just five days per month significantly improved Crohn's disease symptoms and reduced inflammation. The study followed 97 patients with mild-to-moderate Crohn's disease for three months. Participants consumed 700-1,100 calories daily of plant-based meals for five consecutive days monthly, then returned to normal eating. Two-thirds of those following the diet reported symptom improvement, compared to fewer than half in the control group. Importantly, the diet didn't just make patients feel better—it also reduced measurable biological markers of inflammation. This represents a breakthrough for a condition that has long lacked clear dietary guidance, offering doctors evidence-based recommendations for patients who frequently ask what they should eat.
Detailed Summary
Crohn's disease affects roughly one million Americans, causing digestive tract inflammation that leads to diarrhea, cramping, abdominal pain, and weight loss. Until now, patients have received limited dietary guidance, with steroids being the only approved treatment for mild cases—despite serious long-term side effects.
Stanford Medicine researchers conducted a randomized controlled trial with 97 patients across the United States. Sixty-five participants followed a fasting-mimicking diet while 32 continued normal eating habits. The intervention required just five days monthly of calorie restriction to 700-1,100 calories from plant-based meals, followed by normal eating for the remainder of each month.
After three months, approximately two-thirds of fasting-mimicking diet participants reported symptom improvement, compared to fewer than half in the control group. Crucially, benefits appeared after just one cycle and included measurable reductions in inflammation biomarkers—not just subjective symptom relief.
This study addresses a major challenge in dietary research: avoiding placebo effects when participants know which diet they're following. The combination of reported symptom improvement and objective biological markers strengthens the findings' credibility.
The results could transform clinical practice by providing evidence-based dietary recommendations for Crohn's patients. The intermittent nature of the intervention—requiring dietary changes only five days monthly—may improve long-term adherence compared to permanent dietary restrictions. However, patients should consult gastroenterologists before implementing this approach, as individual responses may vary and medical supervision remains important for managing this chronic inflammatory condition.
Key Findings
- Two-thirds of patients following 5-day monthly fasting-mimicking diet reported Crohn's symptom improvement
- Diet reduced measurable inflammation biomarkers, not just subjective symptoms
- Benefits appeared after just one monthly cycle of the intervention
- Only 5 days monthly of 700-1,100 calorie plant-based eating required
- First evidence-based dietary guidance for condition affecting one million Americans
Methodology
This is a news report summarizing a randomized controlled trial published in Nature Medicine. Stanford Medicine conducted the research with high methodological rigor across multiple US sites with 97 participants over three months.
Study Limitations
Article appears truncated mid-sentence. Full study details, participant demographics, specific biomarkers measured, and long-term follow-up data not provided. Individual patient responses may vary significantly.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
